Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linker

Showing results (781-790 of 860) with videos related to

Pageof 86
Sort By:
Journal of the American College of Cardiology|July 21, 2004
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trialAndrew G C Sutton, Philip G Campbell, Richard Graham, et al.
Heart (British Cardiac Society)|September 16, 2005
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trialA G C Sutton, P G Campbell, R Graham, et al.
JAMA|May 5, 2022
Association Between Use of a Flying Intervention Team vs Patient Interhospital Transfer and Time to Endovascular Thrombectomy Among Patients With Acute Ischemic Stroke in Nonurban GermanyGordian J Hubert, Nikolai D Hubert, Christian Maegerlein, et al.
Nature Communications|April 20, 2016
Nuclear RNA-seq of single neurons reveals molecular signatures of activationBenjamin Lacar, Sara B Linker, Baptiste N Jaeger, et al.
Science (New York, N.Y.)|May 1, 2025
Interphase cell morphology defines the mode, symmetry, and outcome of mitosisHolly E Lovegrove, Georgia E Hulmes, Sabrina Ghadaouia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemiaGabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Cell Reports|February 13, 2024
Long interspersed nuclear elements safeguard neural progenitors from precocious differentiationTomohisa Toda, Tracy A Bedrosian, Simon T Schafer, et al.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Pageof 86

Showing results (781-790 of 860) with videos related to

Sort By:
Pageof 86
Journal of the American College of Cardiology|July 21, 2004
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trialAndrew G C Sutton, Philip G Campbell, Richard Graham, et al.
Heart (British Cardiac Society)|September 16, 2005
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trialA G C Sutton, P G Campbell, R Graham, et al.
JAMA|May 5, 2022
Association Between Use of a Flying Intervention Team vs Patient Interhospital Transfer and Time to Endovascular Thrombectomy Among Patients With Acute Ischemic Stroke in Nonurban GermanyGordian J Hubert, Nikolai D Hubert, Christian Maegerlein, et al.
Nature Communications|April 20, 2016
Nuclear RNA-seq of single neurons reveals molecular signatures of activationBenjamin Lacar, Sara B Linker, Baptiste N Jaeger, et al.
Science (New York, N.Y.)|May 1, 2025
Interphase cell morphology defines the mode, symmetry, and outcome of mitosisHolly E Lovegrove, Georgia E Hulmes, Sabrina Ghadaouia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemiaGabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Cell Reports|February 13, 2024
Long interspersed nuclear elements safeguard neural progenitors from precocious differentiationTomohisa Toda, Tracy A Bedrosian, Simon T Schafer, et al.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Pageof 86